{
    "clinical_study": {
        "@rank": "100996", 
        "arm_group": {
            "arm_group_label": "Chronic Heart Failure patients using ASV", 
            "description": "Patients with chronic heart failure who are using or willing to use adaptive servo ventilation (ASV) therapy will be enrolled. Respiratory data will be collected from this group every 3 months over a 12 month period"
        }, 
        "brief_summary": {
            "textblock": "Sleep disordered breathing is very common in patients with chronic heart failure with\n      reported prevalence rates of 50-75%. Adaptive Servo-Ventilation (ASV)  can be used to treat\n      sleep apnea in these patients. This is an observational study to document changes in\n      respiratory parameters in HF patients using ASV for a period of 12 months."
        }, 
        "brief_title": "Adaptive Servo-ventilation Monitoring Study", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        More than 18 years old Chronic heart failure (at least 12 weeks since diagnosis) according\n        to the currently applicable guidelines NYHA Class III or IV at the time of inclusion with\n        at least one hospitalization for heart failure in the last 12 months Moderate to severe\n        sleep apnea (AHI \u2265 15/hour). Already using or willing to use ASV-therapy and able to\n        tolerate the mask treatment\n\n        Exclusion Criteria:\n\n        Planned or scheduled heart valve interventions and/or CABG Untreated or therapy refractory\n        Restless Leg Syndrome Patients for whom the use of positive airway pressure therapy may be\n        contra-indicated because of symptomatic hypotension or significant intravascular volume\n        depletion or pneumothorax or pneumomediastinum Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Chronic Heart Failure patients using adaptive servo ventilation"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02133859", 
            "org_study_id": "MA220414"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 14, 2014", 
        "location": {
            "contact": {
                "email": "ooldenburg@hdz-nrw.de", 
                "last_name": "Olaf Oldenburg, MD", 
                "phone": "05731 / 97-1901"
            }, 
            "facility": {
                "address": {
                    "city": "Bad Oeynhausen", 
                    "country": "Germany", 
                    "state": "North Rhine-Westphalia", 
                    "zip": "D-32545"
                }, 
                "name": "Sleep Laboratory, Ruhr University of Bochum"
            }, 
            "investigator": {
                "last_name": "Olaf Oldenburg, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Feasibilty of Respiratory Monitoring With Adaptive Servoventilation (PaceWave\u2122) to Predict Worsening of Heart Failure in Patients With Severe Heart Failure and Sleep-disordered Breathing", 
        "overall_contact": {
            "email": "ooldenburg@hdz-nrw.de", 
            "last_name": "Olaf Oldenburg, MD", 
            "phone": "05731 / 97-1901"
        }, 
        "overall_official": {
            "affiliation": "Ruhr University of Bochum", 
            "last_name": "Olaf Oldenburg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Hypoxemia, as measured by pulse oximetery will be compared with heart failure status to measure if a correlation exists between hypoxemia and deterioration of heart failure", 
            "measure": "Correlation of hypoxemia, as measured by overnight pulse oximetery, with worsening heart failure", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02133859"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "ResMed", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ResMed", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}